In the BioHarmony Drug Report Database

"Preview" Icon

Lamotrigine

Lamictal, Lamictal Cd, Lamictal Odt (lamotrigine) is a small molecule pharmaceutical. Lamotrigine was first approved as Lamictal on 1994-12-27. It is used to treat bipolar disorder, epilepsy, lennox gastaut syndrome, mood disorders, and partial epilepsies amongst others in the USA. It is known to target sodium channel protein type 2 subunit alpha. Lamictal’s patents are valid until 2029-01-04 (FDA).

 

Trade Name

 

Lamictal, Lamictal Cd, Lamictal Odt
 

Common Name

 

lamotrigine
 

ChEMBL ID

 

CHEMBL741
 

Indication

 

bipolar disorder, epilepsy, lennox gastaut syndrome, mood disorders, partial epilepsies, seizures
 

Drug Class

 

Sodium channel blockers, signal transduction modulators

Image (chem structure or protein)

Lamotrigine structure rendering